retatrutide type 2 diabetes phase 2 trial results 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Lilly's triple agonist delivers up

168 Interestingly, in obesity, IL-6 is associated with IR, whereas during exercise, it may enhance glucose uptake via AMPK activation

Goldberg AD, Allis CD, Bernstein E

Malik F, Li Z (2022) Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: Alternative approaches for treatment of Type 2 diabetes

But retatrutide can also cause a temporary increase in heart rate that needs to be carefully monitored, since it can lead to more serious complications, such as heart arrhythmia, says Dr

Although these medications are often advertised as a short-term strategy, thats not how doctors see them